Omeros Corporation (NASDAQ: OMER) today announced that its Investigational New Drug Application (IND) to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Food and Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an enzyme expressed in areas of the brain linked to a wide range of diseases that affect cognition, including Huntington's disease and schizophrenia. OMS824 has shown promising results in animal models directly relevant to Huntington's disease and, as previously announced, OMS824 was well tolerated ... read more

Alkermes plc (NASDAQ: ALKS) today reported financial results for its fourth quarter and fiscal year ended March 31, 2013. The company also announced that it has changed its fiscal year-end from March 31 to Dec. 31, and provided financial expectations for the nine-month period ending Dec. ... read more

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Deutsche Bank ... read more

Cancer Genetics, Inc. (OTCQB: CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based cancer diagnostics, will present at the second annual Marcum MicroCap Conference on Thursday, May 30, 2013 at 2:30 p.m. ET at the Grand Hyatt New York in New York City. ... read more

ATLANTA, GA -- (Marketwired) -- 05/23/13 -- The second annual Clinical Research in Georgia Conference will be held on December 4th, 2013, at the Academy of Medicine in the heart of midtown Atlanta. The conference is designed to spotlight innovations that can make clinical trials faster, more efficient and more compliant, and showcase the available resources in Georgia that facilitate effective clinical research initiatives. The inaugural 2012 Conference substantially exceeded attendance goals, with more than 200 people registered. The conference ... read more

Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that it has committed to waive down the Acceptance Threshold from 90 percent to 50 percent of Maximum Elan Shares Affected plus one Elan Share in accordance with the terms of the Revised Offer Document issued today, subject to the conditions summarized below. Under the terms of the Increased Offer, Royalty Pharma is offering to acquire Elan (NYSE: ELN) for $12.50 per share in cash. The Increased Offer represents a compelling value of ... read more

RedLightCameraTicket.net (http://redlightcameraticket.net/), a new website for drivers victimized by automated traffic enforcement cameras, is providing motorists with the information required to fight and beat red light and speed camera tickets. As municipalities the world over search for new ways to increase revenues, one method has raised the motoring public's ire like no other: automated traffic law enforcement camera citations. Originally touted as a way to make intersections safer, these computer-driven cameras photograph the offending driver's license plate, resulting in a traffic law ... read more

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced plans for the initiation of the Cedar(TM) clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer. This trial will be the seventh randomized Phase 2 clinical trial evaluating OGX-427 in the treatment of advanced cancers and will investigate whether adding OGX-427 to gemcitabine and carboplatin therapy can extend progression-free survival (PFS) outcomes. Cedar will randomize approximately 140 patients to receive either OGX-427 ... read more

MobileSmith, a leading provider of innovative mobile software solutions for enterprise customers, announced MobileSmith 3.0 - a major new release of its Mobile App Development Platform. The new version features Enterprise App Versioning, a streamlined, more intuitive UI, important security enhancements, improved Training & Support center, and many exciting new features. "MobileSmith 3.0 will completely transform your enterprise mobile app development and management experience," said Bob Dieterle, Senior VP and COO of MobileSmith. "Not only does our Platform enable rapid prototyping ... read more

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Jefferies Healthcare Conference in New York. James Winschel, Sr. Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 1:30 p.m. ET on Monday, June 3, 2013. A live webcast of the presentation will be available through the "Investors" section of PAREXEL's website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay of ... read more

Marketo, (MKTO) the provider of a leading cloud-based marketing software platform, today announced Marketo Financial Management (MFM), the first application in its new Marketing Management product family. This fifth new family of applications is aimed squarely at meeting the broad needs of marketing operations. (Logo: http://photos.prnewswire.com/prnh/20070917/AQM011LOGO) Marketing teams struggle to track the spending across all the marketing programs they have in flight, making it hard to stay on budget. Marketo Financial Management does away with that by giving marketers an up-to-date view ... read more

Hillcrest Labs today announced that TCL Multimedia has signed a new multi-year agreement to extend the use of Hillcrest's patented Freespace(®) in-air pointing and motion control software in TCL's Internet-connected Smart TVs. Freespace enables small in-air movements of remote controls to move a cursor around the TV screen. This allows users to navigate their TV user interface with point-and-click controls, just like they do on computers, smartphones and tablets. In May of 2012, Hillcrest announced a partnership with TCL and introduced ... read more

Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced preliminary results from the ADVISE (Adenosine Vasodilator Independent Stenosis Evaluation) II trial during the hot line late breaking clinical trial session at EuroPCR 2013. These prospective results confirm prior retrospective publications, and demonstrate the clinical usefulness of an iFR(®)/Fractional Flow Reserve (FFR) Hybrid approach to simplify lesion assessment and to save ... read more

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that the company’s EnligHTN™ Multi-Electrode Renal Denervation System provides a safe, rapid and sustained reduction in blood pressure measurements after one year. The new one year study data from the EnligHTN I trial was ... read more

Email Aptitude, a leading email strategy and marketing technology firm, announced today that it has implemented key additions to its patent-pending EA Rainmaker technology. These enhancements include real-time coverage for Canada plus the ability to schedule forecast triggers based on temperature dips and spikes. (Photo: http://photos.prnewswire.com/prnh/20130523/CG18528) The EA Rainmaker technology already covers every US zip code in real-time and now accommodates every city, territory, and province in Canada. This added coverage allows marketers on any ESP to create targeted email ... read more

Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced that it has entered into an agreement to divest its Targeted Therapies business to BTG plc (LSE: BTG) (“BTG”), an international specialist healthcare company based ... read more

H2 (h2.co), an exclusive leadership network consisting of 250 of the technology industry's most influential operating executives across 9 global chapters, announced today the availability of key new offerings in conjunction with the 3-year anniversary of its first events. In addition to signature Member Forums held bi-monthly in each chapter, H2 is now broadening its offerings to include a set of integrated online member community tools as well as an annual global conference, H2O (h2.co/h2o), to be held in its ... read more

X-Rite, Incorporated and Pantone LLC, today announced that Procter & Gamble (NYSE: PG), the company behind consumer brands including Gillette(®), Tide(®) and Pampers(®), has implemented PantoneLIVE(TM), a cloud-based color service, to improve operational efficiency in packaging execution. With color so critically tied to brand equity, maintaining color consistency on product packaging is essential for brand recognition and ensuring consumer confidence and delight. (Logo: http://photos.prnewswire.com/prnh/20130523/SF19359LOGO) (Logo: http://photos.prnewswire.com/prnh/20130418/SF93634LOGO-b) "PantoneLIVE is an efficient, effective and seamless technology that saves time and money, and helps ensure design ... read more

Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today that the Company will present at the Stifel Dental & Veterinary 2013 Conference on Wednesday, May 29, 2013 at the Le Parker Meridian hotel, 119 W. 56(th) Street in New York City. The presentation is scheduled to begin at 2:15 p.m. Eastern Time in the Estrella Room. About HeskaHeska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and other specialty veterinary ... read more

Agilent Technologies Inc. (NYSE: A), the Glyco-MEV laboratory at the University of Rouen, in France, and the Bioprocessing Technology Institute at the Agency for Science, Technology and Research (A*STAR), in Singapore, have signed a memorandum of understanding to work together in order to develop tools to ... read more